173 related articles for article (PubMed ID: 8990261)
1. Heme-coordinating analogs of lauric acid as inhibitors of fatty acid omega-hydroxylation.
Lu P; Alterman MA; Chaurasia CS; Bambal RB; Hanzlik RP
Arch Biochem Biophys; 1997 Jan; 337(1):1-7. PubMed ID: 8990261
[TBL] [Abstract][Full Text] [Related]
2. Effects of steric bulk and conformational rigidity on fatty acid omega hydroxylation by a cytochrome P450 4A1 fusion protein.
Bambal RB; Hanzlik RP
Arch Biochem Biophys; 1996 Oct; 334(1):59-66. PubMed ID: 8837739
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
[TBL] [Abstract][Full Text] [Related]
4. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes.
Amet Y; Lucas D; Zhang-Gouillon ZQ; French SW
Alcohol Clin Exp Res; 1998 Apr; 22(2):455-62. PubMed ID: 9581653
[TBL] [Abstract][Full Text] [Related]
5. Heteroatom substitution shifts regioselectivity of lauric acid metabolism from omega-hydroxylation to (omega-1)-oxidation.
Alterman MA; Chaurasia CS; Lu P; Hanzlik RP
Biochem Biophys Res Commun; 1995 Sep; 214(3):1089-94. PubMed ID: 7575514
[TBL] [Abstract][Full Text] [Related]
6. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
Boucher JL; Delaforge M; Salaün JP; Pinot F; Durst F; Pflieger P; Mioskowski C
Drug Metab Dispos; 1996 Apr; 24(4):462-8. PubMed ID: 8801062
[TBL] [Abstract][Full Text] [Related]
7. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
[TBL] [Abstract][Full Text] [Related]
8. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes.
Powell PK; Wolf I; Lasker JM
Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854
[TBL] [Abstract][Full Text] [Related]
9. Active site structure and substrate specificity of cytochrome P450 4A1: steric control of ligand approach perpendicular to heme plane.
Bambal RB; Hanzlik RP
Biochem Biophys Res Commun; 1996 Feb; 219(2):445-9. PubMed ID: 8605007
[TBL] [Abstract][Full Text] [Related]
10. Effect of phenobarbital treatment and cytochrome P-450 inhibitors on the laurate omega- and (omega - 1)-hydroxylase activities of rat liver microsomes.
Okita RT; Masters BS
Drug Metab Dispos; 1980; 8(3):147-51. PubMed ID: 6104577
[TBL] [Abstract][Full Text] [Related]
11. Expression of rabbit cytochromes P4504A which catalyze the omega-hydroxylation of arachidonic acid, fatty acids, and prostaglandins.
Roman LJ; Palmer CN; Clark JE; Muerhoff AS; Griffin KJ; Johnson EF; Masters BS
Arch Biochem Biophys; 1993 Nov; 307(1):57-65. PubMed ID: 8239664
[TBL] [Abstract][Full Text] [Related]
12. Omega- and (omega-1)-hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450.
Imaoka S; Tanaka S; Funae Y
Biochem Int; 1989 Apr; 18(4):731-40. PubMed ID: 2504167
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
[TBL] [Abstract][Full Text] [Related]
14. A novel rat hepatic clofibrate-inducible cytochrome P450 that is not a lauric acid hydroxylase.
Swinney DC; Webb AS; Freedman R
Biochem Pharmacol; 1991 Nov; 42(12):2341-9. PubMed ID: 1662512
[TBL] [Abstract][Full Text] [Related]
15. 10-Undecynoic acid, an inhibitor of cytochrome P450 4A1, inhibits ethanolamine-specific phospholipid base exchange reaction in rat liver microsomes.
Lenart J; Pikuła S
Acta Biochim Pol; 1999; 46(1):203-10. PubMed ID: 10453996
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid discrimination and omega-hydroxylation by cytochrome P450 4A1 and a cytochrome P4504A1/NADPH-P450 reductase fusion protein.
Alterman MA; Chaurasia CS; Lu P; Hardwick JP; Hanzlik RP
Arch Biochem Biophys; 1995 Jul; 320(2):289-96. PubMed ID: 7625836
[TBL] [Abstract][Full Text] [Related]
17. Alcohol consumption enhances fatty acid omega-oxidation, with a greater increase in male than in female rats.
Ma X; Baraona E; Lieber CS
Hepatology; 1993 Nov; 18(5):1247-53. PubMed ID: 8225232
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid omega- and (omega-1)-hydroxylation in experimental alcoholic liver disease: relationship to different dietary fatty acids.
Amet Y; Adas F; Nanji AA
Alcohol Clin Exp Res; 1998 Oct; 22(7):1493-500. PubMed ID: 9802534
[TBL] [Abstract][Full Text] [Related]
19. Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole.
Dierks EA; Davis SC; Ortiz de Montellano PR
Biochemistry; 1998 Feb; 37(7):1839-47. PubMed ID: 9485309
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors.
Wang MH; Brand-Schieber E; Zand BA; Nguyen X; Falck JR; Balu N; Schwartzman ML
J Pharmacol Exp Ther; 1998 Mar; 284(3):966-73. PubMed ID: 9495856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
